0001181431-12-035283.txt : 20120607
0001181431-12-035283.hdr.sgml : 20120607
20120607181457
ACCESSION NUMBER: 0001181431-12-035283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120606
FILED AS OF DATE: 20120607
DATE AS OF CHANGE: 20120607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEDOUX MARK A
CENTRAL INDEX KEY: 0001115556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15701
FILM NUMBER: 12895782
MAIL ADDRESS:
STREET 1: 1185 LINDA VISTA DR
CITY: SAN MARCOS
STATE: CA
ZIP: 92069
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC
CENTRAL INDEX KEY: 0000787253
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 841007839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1185 LINDA VISTA DR
CITY: SAN MARCOS
STATE: CA
ZIP: 92069
BUSINESS PHONE: 6197447340
MAIL ADDRESS:
STREET 1: 1185 LINDA VISTA DRIVE
CITY: SAN MARCOS
STATE: CA
ZIP: 92069
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC
DATE OF NAME CHANGE: 19860929
4
1
rrd348013.xml
LEDOUX FORM 4
X0305
4
2012-06-06
0
0000787253
NATURAL ALTERNATIVES INTERNATIONAL INC
NAII
0001115556
LEDOUX MARK A
1185 LINDA VISTA DR
SAN MARCOS
CA
92078
1
1
1
0
CEO/Chairman
Common Stock
2012-06-06
4
S
0
10000
6.74
D
185037
D
Common Stock
2012-06-07
4
G
0
2000
D
183037
D
Common Stock
2012-06-06
4
S
0
20000
6.74
D
557851
I
By LeDoux Family Limited Partnership
Common Stock
41416
I
By IRA
Common Stock
7200
I
By Self as Custodian for Marcelle Jeannette LeDoux
Common Stock
800
I
By Self as Custodian for Jean-Marc Emile LeDoux
Common Stock
28000
I
By 401(K)
Common Stock
36677
I
By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992
This transaction represents a repurchase of common stock by the Company in a private transaction. The repurchase was approved by the Audit Committee and the independent members of the Company's Board of Directors on May 25, 2012.
The approval of the Company's Audit Committee and Board of Directors was conditioned on a purchase price equal to 90% of the closing price of the Company's common stock as reported by Nasdaq on June 1, 2012, which date represented the third day after the filing by the Company of a Current Report on Form 8-K reporting the approval of the repurchase. The closing price on June 1, 2012 as reported by Nasdaq was $7.49.
This transaction represents a donation of the shares to a private institution.
/s/ Ken Wolf on behalf of Mr. LeDoux pursuant to a Power of Attorney
2012-06-07